Search

everythinglearnresearchcommunity

for

Search:↓

Chemotherapy for breast cancer often causes significant and lasting hair loss.

Topical radioprotectors can reduce radiation-induced hair loss.

Chemotherapy often causes hair loss, which is distressing for many, but usually reversible.

CHOP chemotherapy for non-Hodgkin's lymphoma commonly causes hair loss, fatigue, taste changes, and nausea.

Taxane-based chemotherapy causes more hair loss and skin changes in Asian breast cancer patients.

New cancer treatments are less harmful to hair but can still cause hair loss, color, shape, and growth changes.

Cryotherapy helps reduce chemotherapy side effects but needs more research for best use.

Targeted cancer therapies often cause skin reactions, so dermatologists must manage these effects.

Skin side effects from melanoma immunotherapy are common and may indicate better survival.

Some breast cancer treatments caused long-term hair loss in women, similar to a condition called alopecia areata.

Bortezomib chemotherapy can cause temporary skin rashes.

Adverse events in lung cancer treatments increase fear, anxiety, and depression, with newer therapies causing fewer side effects.

Tamoxifen can cause total hair loss but its benefits outweigh this side effect.

Tyrosine kinase inhibitors effectively treat cancers but often cause skin and other side effects.

More research is needed to understand chemotherapy-induced hair loss and its phases.

Self-care strategies, especially diet and lifestyle changes, help manage cancer treatment symptoms.

Targeted radionuclide therapy shows promise for improving head and neck cancer treatment but needs more research.

Nutritional education reduces chemotherapy side effects and improves health in breast cancer patients.

Scalp cooling effectively prevents chemotherapy-induced hair loss but requires better pain management.

The cancer drugs bortezomib and lenalidomide cause skin side effects in many patients.

Most children with CNS tumors on targeted therapy had skin reactions, which were generally treatable without stopping the therapy.

Tyrosine Kinase Inhibitors are effective against cancer but can cause skin, digestive, and blood side effects, including hair loss.

EGFR cancer drugs often cause a rash, which can lead to distress and isolation, but may also improve outcomes for some cancer patients. Current treatments for the rash are limited, but a compound called menadione shows promise.

Vemurafenib causes significant skin side effects, requiring regular dermatologist care and sun protection.

Hair loss is a common but often unreported side effect of cancer treatments, especially for breast and prostate cancers.

Subcutaneous trastuzumab improves some symptoms and doesn't harm overall quality of life in breast cancer patients.

Chemotherapy often causes hair loss, mouth sores, and dry skin.

Excessive eyelash growth from erlotinib may indicate positive tumor response and help treat madarosis.

CHOP chemotherapy causes many side effects but is generally well tolerated.

Some supplements may help reduce side effects of cancer treatments in pets.